glp-1 hfpef New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review Superior cardiovascular protection with GLP-1

Only Medullary Thyroid Carcinoma (MTC) is a strict contraindication

Why employers are facing a tough decision Why covering GLP-1s is a costly challenge for employers GLP-1 medications like Wegovy and Ozempic are among the most expensive prescription drugs available today

Policy makers have a responsibility to ensure that evidence-based interventions are available and affordable to all

Intake, labs, prescriptions, and ongoing coaching are all handled through one easy-to-use app

References Bezin J, Gouverneur A, Pnichon M, et al

The anti-inflammatory mechanisms of GLP-1RAs include that they can reduce inflammation through inhibition of nuclear factor kappa B (NF-B) signalling, can reduce proinflammatory cytokine signalling (these cytokines are also released by mast cells), and can modulate immune cell activity